Fatty kidney: A possible future for chronic kidney disease research
Open Access
- 18 January 2022
- journal article
- review article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 52 (6) , e13748
Abstract
Background: Metabolic syndrome is a growing twenty‐first century pandemic associated with multiple clinical comorbidities ranging from cardiovascular diseases, non‐alcoholic fatty liver disease and polycystic ovary syndrome to kidney dysfunction. A novel area of research investigates the concept of fatty kidney in the pathogenesis of chronic kidney disease, especially in patients with diabetes mellitus or metabolic syndrome.Aim: To review the most updated literature on fatty kidney and provide future research, diagnostic and therapeutic perspectives on a disease increasingly affecting the contemporary world.Materials and Method: We performed an extensive literature search through three databases including Embase (Elsevier) and the Cochrane Central Register of Controlled Trials (Wiley) and PubMed/Medline Web of Science in November 2021 by using the following terms and their combinations: ‘fatty kidney’, ‘ectopic fat’, ‘chronic kidney disease’, ‘cardiovascular event’, ‘cardio‐metabolic risk’, ‘albuminuria’ and ‘metabolic syndrome’. Each study has been individually assessed by the authors.Results: Oxidative stress and inflammation, Klotho deficiency, endoplasmic reticulum stress, mitochondrial dysfunction and disruption of cellular energy balance appear to be the main pathophysiological mechanisms leading to tissue damage following fat accumulation. Despite the lack of large‐scale comprehensive studies in this novel field of research, current clinical trials demonstrate fatty kidney as an independent risk factor for the development of chronic kidney disease and cardiovascular events.Conclusion: The requirement for future studies investigating the pathophysiology, clinical outcomes and therapeutics of fatty kidney is clear.Keywords
This publication has 145 references indexed in Scilit:
- Standardized Ultrasound Hepatic/Renal Ratio and Hepatic Attenuation Rate to Quantify Liver Fat Content: An Improvement MethodObesity, 2012
- Fatty Kidney, Hypertension, and Chronic Kidney DiseaseHypertension, 2011
- AMPK Mediates the Initiation of Kidney Disease Induced by a High-Fat DietJournal of the American Society of Nephrology, 2011
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trialThe Lancet, 2011
- Renal Sinus Fat and Poor Blood Pressure Control in Middle-Aged and Elderly Individuals at Risk for Cardiovascular EventsHypertension, 2010
- Regulation of podocyte survival and endoplasmic reticulum stress by fatty acidsAmerican Journal of Physiology-Renal Physiology, 2010
- Diabetes reduces the cholesterol exporter ABCA1 in mouse macrophages and kidneysJournal of Lipid Research, 2010
- Cyclodextrin overcomes the transport defect in nearly every organ of NPC1 mice leading to excretion of sequestered cholesterol as bile acidJournal of Lipid Research, 2010
- Multiple Metabolic Hits Converge on CD36 as Novel Mediator of Tubular Epithelial Apoptosis in Diabetic NephropathyPLOS Medicine, 2005
- The Renal Sinus: Pathologic Spectrum and Multimodality Imaging ApproachRadioGraphics, 2004